We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
-0.56%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$81.3B
AUM Growth
-$1.18B
Cap. Flow
+$158M
Cap. Flow %
0.19%
Top 10 Hldgs %
39.76%
Holding
963
New
137
Increased
344
Reduced
325
Closed
77

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$967M
2
CRM icon
Salesforce
CRM
+$381M
3
BABA icon
Alibaba
BABA
+$184M
4
CMI icon
Cummins
CMI
+$125M
5
TMUS icon
T-Mobile US
TMUS
+$83.7M

Top Sells

Rank Stock Value
1
DE icon
Deere & Co
DE
+$748M
2
EXPD icon
Expeditors International
EXPD
+$212M
3
CERN
Cerner Corp
CERN
+$179M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$116M
5
MTB icon
M&T Bank
MTB
+$105M

Sector Composition

Rank Sector Weight
1 Technology 27.82%
2 Consumer Discretionary 14.99%
3 Communication Services 14.18%
4 Healthcare 13.76%
5 Industrials 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFN icon
201
Lakeland Financial Corp
LKFN
$1.53B
$38.3M 0.05%
537,449
+109,287
+26% +$7.11M
BWIN
202
Baldwin Insurance Group
BWIN
$2.86B
$37.8M 0.05%
+1,136,635
New +$35.6M
PRFT
203
DELISTED
Perficient Inc
PRFT
$37.7M 0.05%
325,885
-4,858
-1% -$500K
MORN icon
204
Morningstar
MORN
$7.53B
$37.5M 0.05%
144,959
+4,039
+3% +$1.06M
HZNP
205
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$37.5M 0.05%
341,965
+9,730
+3% +$1.01M
NVMI
206
Nova
NVMI
$12.5B
$36.9M 0.05%
360,495
+10,032
+3% +$995K
TECH icon
207
Bio-Techne
TECH
$11.3B
$36.9M 0.05%
304,328
-87,500
-22% -$10.6M
NOMD icon
208
Nomad Foods
NOMD
$1.68B
$36.7M 0.05%
1,333,419
-20,444
-2% -$555K
WLL
209
DELISTED
Whiting Petroleum Corporation
WLL
$36.6M 0.05%
626,433
-291,259
-32% -$14.4M
LASR icon
210
nLIGHT
LASR
$3.17B
$36.2M 0.04%
1,285,434
-19,943
-2% -$594K
OXM icon
211
Oxford Industries
OXM
$552M
$35.8M 0.04%
397,046
+36,945
+10% +$3.36M
BMRN icon
212
BioMarin Pharmaceuticals
BMRN
$12.4B
$35.8M 0.04%
462,757
+2,684
+0.6% +$212K
SWTX
213
DELISTED
SpringWorks Therapeutics
SWTX
$35.3M 0.04%
556,940
-8,638
-2% -$666K
MKSI icon
214
MKS Inc
MKSI
$20.6B
$35.3M 0.04%
234,122
-60,793
-21% -$9.33M
AVLR
215
DELISTED
Avalara, Inc.
AVLR
$35.2M 0.04%
201,281
+14,083
+8% +$2.42M
TRMB icon
216
Trimble
TRMB
$13.9B
$35M 0.04%
425,485
+12,126
+3% +$1.06M
PACK icon
217
Ranpak Holdings
PACK
$473M
$35M 0.04%
+1,304,763
New +$36.7M
ELF icon
218
e.l.f. Beauty
ELF
$5.81B
$34.2M 0.04%
+1,178,734
New +$33.7M
INSM icon
219
Insmed
INSM
$28.6B
$34M 0.04%
1,234,661
+459,411
+59% +$12.1M
BR icon
220
Broadridge
BR
$19B
$34M 0.04%
203,907
+5,678
+3% +$967K
CALX icon
221
Calix
CALX
$2.39B
$33.8M 0.04%
+684,781
New +$31.6M
REPL icon
222
Replimune Group
REPL
$1.01B
$33.7M 0.04%
1,136,066
+143,473
+14% +$4.66M
VVV icon
223
Valvoline
VVV
$4.51B
$33.6M 0.04%
1,077,916
-5,441
-0.5% -$169K
BMY icon
224
Bristol-Myers Squibb
BMY
$132B
$33.5M 0.04%
566,230
-1,310,346
-70% -$86.3M
CRL icon
225
Charles River Laboratories
CRL
$12.8B
$33.1M 0.04%
80,223
-37,702
-32% -$15.7M
7 8
9
10 11

Similar funds

CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Loomis, Sayles & Company's Q3 2021 Portfolio in Review

As of Q3 2021, Loomis, Sayles & Company held 963 positions worth $81.3B, down 1.4% from $82.5B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Loomis, Sayles & Company's Q3 2021 filing shows 137 new, 344 increased, 325 reduced and 77 closed positions. Its largest new stake was Helios Technologies: 474,902 shares worth $39M. The largest sale was Deere & Co, an estimated $748M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q3 2021 buy was Helios Technologies: 474,902 shares worth $39M.
  • Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q3 2021, an estimated $967M increase.
  • Loomis, Sayles & Company's biggest Q3 2021 reduction was Deere & Co, cutting an estimated $748M.
  • Loomis, Sayles & Company fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $116M.
  • Loomis, Sayles & Company's ten largest holdings make up 40% of its $81.3B portfolio in Q3 2021.
  • Loomis, Sayles & Company opened 137 new positions and closed 77 in Q3 2021.
  • Loomis, Sayles & Company's portfolio value fell 1.4% quarter-over-quarter to $81.3B.

Based on Loomis, Sayles & Company's 13F filing for Q3 2021, filed 12 Nov 2021.